42: Pulmonary Hypertension

Published on 06/02/2015 by admin

Filed under Anesthesiology

Last modified 06/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1131 times

CHAPTER 42 Pulmonary Hypertension

3 Discuss the pathophysiology and natural history of pulmonary hypertension

Endothelial cell injury leads to imbalances between vasodilator and vasopressor molecules. Reductions in the endogenous vasodilators nitric oxide (NO) and prostacyclin (PGI2) are noted, whereas the vasoconstrictors thromboxane and endothelin are increased. But vasoconstriction appears to be only part of the answer because thrombosis, inflammation, free radical generation, and smooth muscle hyperplasia are also common features noted in PH. Indeed, vascular remodeling is a prominent feature of PH.

The pulmonary circulation has high flow and low resistance. Changes in CO, airway pressure, and gravity affect the pulmonary circulation more than the systemic circulation. The right ventricle is thin walled and accommodates changes in volume better than changes in pressure. To accommodate increases in flow such as during exercise, unopened vessels are recruited, patent vessels distended, and pulmonary vascular resistance (PVR) may decrease. Such normal adaptive mechanisms can accommodate threefold to fivefold increases in flow without significant increases in PAPs.

Early in the evolution of PH, the pressure overload results in hypertrophy of the right ventricle without significant changes in CO or RV filling pressures either at rest or during exercise. As the disease progresses, the vessel walls thicken and smooth muscle cells hypertrophy and increase in number. Vessels become less distensible, and the actual cross-sectional area of the pulmonary circulation decreases. Initially with exercise CO eventually declines despite modest increases in right ventricular (RV) end-diastolic pressures (RVEDP). Mechanisms for enhancing contractility are few for the right ventricle. In time, RV failure (RV ejection fraction below 45%) ensues, and the patient is symptomatic even at rest. RV myocardial blood flow becomes compromised, and tricuspid regurgitation develops secondary to right ventricle distention, further increasing RVEDP and worsening failure. In addition, left ventricular (LV) diastolic function may deteriorate, and LV filling may be compromised by excessive septal incursion into the left ventricle, with a resultant decrease in CO.

Without treatment PH is universally fatal, with a mean survival of 2.8 years. One-, 3, and 5-year survival rates are 68%, 48%, and 34%, respectively. The mortality rate during pregnancy is 30% to 50%, and most experts recommend early termination of pregnancy in these women should pregnancy occur.